Study To Evaluate The Efficacy And Long-Term Adherence Of Spondyloarthropathies(SpA) Patients On Enbrel

Pfizer

Status: Completed

Conditions: Spondyloarthrosis

Treatments: Drug: Etanercept

Study type: Observational

Funder types: Industry

Identifiers

NCT04507776

B1801414

Details and patient eligibility

About

This study is to evaluate local data in Iraqi patients with Spondyloarthropathies on Enbrel treatment with regards to efficacy and adherence using data from the Baghdad Teaching Hospital (Rheumatology Center)

Enrollment: 763 patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Diagnosed SpA patients
• 18 years of age and older.
• Did not receive previous other biological treatments.
• Patients have at least 1 year on Enbrel.

Exclusion criteria

• Had previously used another biological treatments.
• Use of etanercept for less than 1 year duration.

Trial design

763 participants in 1 patient group

Patients with spondyloarthropathies

Description:

Patients with spondyloarthrosis that received Etanercept as treatment for disease

Treatment:

Drug: Etanercept